Ventilator-associated pneumonia in a tertiary care hospital in India: role of multi-drug resistant pathogens.
BACKGROUND
Ventilator-Associated Pneumonia (VAP) is the most frequent intensive-care-unit (ICU)-acquired infection. The aetiology of VAP varies with different patient populations and types of ICUs.


METHODS
A prospective study was performed over a period of 15 months in a tertiary care hospital to determine the various aetiological agents causing VAP and the prevalence of multidrug resistant (MDR) pathogens. Combination disk method, Modified Hodge test, EDTA disk synergy (EDS) test and AmpC disk test were performed for the detection of extended spectrum beta-lactamases (ESBL), carbapenemases, metallo-beta-lactamases (MBL) and AmpC beta-lactamases respectively.


RESULTS
Enterobacteriaceae, Haemophilus influenzae, Staphylococcus aureus, Streptococcus pneumoniae, Candida spp. were more common in early-onset VAP, while non-fermenters (Pseudomonas spp. and Acinetobacter spp.) were significantly associated with late-onset VAP (P value 0.0267, Chi-square value 4.91). Thirty-seven (78.7%) of the 47 VAP pathogens were multidrug resistant. ESBL was produced by 50% and 67% of Escherichia coli and Klebsiella pneumoniae respectively. MBL was produced by 20% of P. aeruginosa. AmpC beta-lactamases were produced by 33.3% and 60.7% of the Enterobacteriaceae and non-fermenters respectively. Of the S. aureus isolates, 43% were methicillin resistant. Prior antibiotic therapy and hospitalization of five days or more were independent risk factors for VAP by MDR pathogens.


CONCLUSIONS
VAP is increasingly associated with MDR pathogens. Production of ESBL, AmpC beta-lactamases and metallo beta-lactamases were responsible for the multi-drug resistance of these pathogens. Increasing prevalence of MDR pathogens in patients with late-onset VAP indicate that appropriate broad-spectrum antibiotics should be used to treat them.
Joseph
Noyal Mariya
NM
Mahatma Gandhi Medical College and Research Institute, Pondicherry, India. noyaljoseph@yahoo.com
Sistla
Sujatha
S
Dutta
Tarun Kumar
TK
Badhe
Ashok Shankar
AS
Rasitha
Desdemona
D
Parija
Subhash Chandra
SC
D001419:Bacteria / Q000187:drug effects* / Q000302:isolation & purification*; D001426:Bacterial Proteins / Q000096:biosynthesis; D016638:Critical Illness; D024901:Drug Resistance, Multiple, Bacterial; D005658:Fungi / Q000302:isolation & purification*; D006761:Hospitals; D006801:Humans; D007194:India; D008826:Microbial Sensitivity Tests; D053717:Pneumonia, Ventilator-Associated / Q000382:microbiology*; D015995:Prevalence; D011446:Prospective Studies; D001618:beta-Lactamases / Q000096:biosynthesis
D001426:Bacterial Proteins; D001618:beta-Lactamases